Germany vs Latvia: Previously treated cases tested for RR-/MDR-TB
Germany
80.0%
in 2024
Latvia
80.0%
in 2022
Germany rank
114th
Latvia rank
114th
Previously treated cases tested for RR-/MDR-TB over time
- Germany
- Latvia
How they compare
Germany currently reports 80.0% against 80.0% in Latvia, a difference of 0.0%.
Across all 15 years both countries report, Latvia has been ahead every year.
Germany ranks 114th and Latvia ranks 114th of 180 countries.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Germany | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 52.0% | 92.4% | 40.4% | Latvia |
| 2010s | 45.9% | 88.1% | 42.2% | Latvia |
| 2020s | 73.0% | 86.0% | 13.0% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Germany or Latvia?
- Germany, at 80.0% against 80.0% in Latvia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Germany and Latvia?
- 0.0%, with Germany ahead.
- How many years of comparable data are there for Germany and Latvia?
- 15 years are reported by both, from 2005 to 2022.
- How do Germany and Latvia rank globally for previously treated cases tested for rr-/mdr-tb?
- Germany ranks 114th and Latvia ranks 114th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.